Synonyms: | |
Status: | Approved (1989) |
Entry Type: | Protein |
Molecule Category: | Parent |
ATC: | L02AE03 |
UNII: | 0F65R8P09N |
InChI Key | BLCLNMBMMGCOAS-URPVMXJPSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C59H84N18O14 |
Molecular Weight | 1269.43 |
AlogP | None |
Hydrogen Bond Acceptor | None |
Hydrogen Bond Donor | None |
Number of Rotational Bond | None |
Polar Surface Area | None |
Molecular species | None |
Aromatic Rings | None |
Heavy Atoms | None |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Leiomyoma | 3 | D007889 | ClinicalTrials |
Prostatic Neoplasms | 3 | D011471 | ClinicalTrials |
Breast Neoplasms | 3 | D001943 | ClinicalTrials |
Endometriosis | 3 | D004715 | ClinicalTrials |
Prostatic Neoplasms | 3 | D011471 | ClinicalTrials |
Infertility | 3 | D007246 | ClinicalTrials |
Breast Neoplasms | 3 | D001943 | ClinicalTrials |
Breast Neoplasms | 3 | D001943 | ClinicalTrials |
Prostatic Neoplasms, Castration-Resistant | 3 | D064129 | ClinicalTrials |
Prostatic Neoplasms | 3 | D011471 | ClinicalTrials |
Metabolic Syndrome | 2 | D024821 | ClinicalTrials |
Primary Ovarian Insufficiency | 2 | D016649 | ClinicalTrials |
Hodgkin Disease | 2 | D006689 | ClinicalTrials |
Carcinoma, Lobular | 2 | D018275 | ClinicalTrials |
Adenomyosis | 2 | D062788 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 65807-02-5 |
ChEBI | 5523 |
ChEMBL | CHEMBL1201247 |
DrugBank | DB00014 |
DrugCentral | 1327 |
EPA CompTox | DTXSID7048297 |
FDA SRS | 0F65R8P09N |
Human Metabolome Database | HMDB0014259 |
Guide to Pharmacology | 3879 |
PubChem | 5311128 |
SureChEMBL | SCHEMBL19712239 |